Versant, Lilly back $100M startup to tackle gene therapy delivery hurdle
Published 2 d ago1 sourceEvidence: Reported
Kos Biotechnology Partners, a fund with €111 million, is establishing a biotech hub in Crete and plans to close four new deals by end of 2026, focusing on biotech, pharma discovery, and specialized services. This signals increased private investment in Greek biotech infrastructure, but deal specifics and impact remain unclear.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago5 sourcesEvidence: Reported
Published 12 h ago3 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 13 h ago1 sourceEvidence: Reported
Published 3 h ago6 sourcesEvidence: Reported
Published 1 d ago8 sourcesEvidence: Reported